Company enters 2026 with over $70 million in cash, two positive Phase 2 programs, FDA Fast Track Designation and runway well into 2027 ...

Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center, positioning the company for ...

Wednesday to advance a series of updates to a proposed cannabis program in unincorporated areas, including rules related to ...

The next Medical Device User Fee Amendments, which will set how much the FDA can raise from the industry in fees over a ...

Nigeria's upstream oil regulator has launched an ambitious transformation agenda aimed at accelerating production and ...

State officials warn of staffing, funding and technology hurdles as counties brace for added burden of Medicaid eligibility checks.